About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03374527

Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis

The aim of the study is to investigate the link between pro-inflammatory T cells responses arising in the skin in patients with cutaneous psoriasis and those present in the joints of patients developi...

Lead sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with a diagnosis of cutaneous psoriasis without clinical signs of PsA,
•Patients with a diagnosis of PsA
•Healthy subjects with a negative family and personal anamnesis for psoriasis.
•Absence of acute and chronic systemic or cutaneous infections during sample collections.

Exclusion Criteria

•Treatment with cyclosporin A, methotrexate, systemic corticosteroids or any other immunosuppressant agent within 3 weeks before the blood samples collections.

Related studies

RECRUITINGPhase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · Psoriatic Arthritis

RECRUITINGPhase 2

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07474792 · Plaque Psoriasis

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 4

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942 · Psoriasis, Overweight or Obesity

RECRUITINGPhase 3

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453 · Plaque Psoriasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 9, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment110

Start dateOct 2014

Last updatedSep 9, 2019

Condition

Psoriasis Psoriatic Arthritis

Locations shown

IRCCS Galeazzi Orthopedic Hospital

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions